Results 81 to 89 of about 631 (89)

Effects of diltiazem on pharmacokinetics of tacrolimus in relation to CYP3A5 genotype status in renal recipients: from retrospective to prospective

Pharmacogenomics Journal, 2010
Q Fu
exaly  

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

European Journal of Clinical Pharmacology, 2004
Amalio Telenti, Clara Benzi Schmid, Pierre Baumann   +2 more
exaly  

Functionally Defective or Altered CYP3A4 and CYP3A5 Single Nucleotide Polymorphisms and Their Detection with Genotyping Tests

Pharmacogenomics, 2005
Su-Jun Lee, Joyce A Goldstein
exaly  

CYP3A5 gene polymorphism and risk of prostate cancer in a Japanese population

Cancer Letters, 2005
Yohei Horikawa, Takamitsu Inoue, Tomonori Habuchi   +2 more
exaly  

Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects

European Journal of Clinical Pharmacology, 2008
Kyoung-Ah Kim, Ji-Young Park, Pil-Whan Park   +2 more
exaly  

CYP3A5 phenotype-genotype correlations in a British population

British Journal of Clinical Pharmacology, 2003
Ann K Daly, Faith M Williams, Julian B S Leathart   +2 more
exaly  

CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine

Pharmacogenomics Journal, 2008
Juliane Bolbrinker, Joachim Beige, Friedo Dekker   +2 more
exaly  

The impact of CYP3A5*3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically-based pharmacokinetic model

British Journal of Clinical Pharmacology, 2015
Tsuyoshi Fukuda, Chie Emoto, Raja Venkatasubramanian   +2 more
exaly  

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Voriconazole in Chinese Kidney Transplant Patients

Annals of Pharmacotherapy
Yue Du, Yundi Zhang
exaly